Incanthera (AQSE:INC) Days Payable : 0.00 (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Incanthera Days Payable?

Incanthera's average Accounts Payable for the six months ended in Sep. 2023 was £0.39 Mil. Incanthera's Cost of Goods Sold for the six months ended in Sep. 2023 was £0.00 Mil.

The historical rank and industry rank for Incanthera's Days Payable or its related term are showing as below:

AQSE:INC's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 148.78
* Ranked among companies with meaningful Days Payable only.

Incanthera's Days Payable stayed the same from Sep. 2022 (0.00) to Sep. 2023 (0.00).

Incanthera Days Payable Historical Data

The historical data trend for Incanthera's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Days Payable Chart

Incanthera Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Days Payable

Incanthera Semi-Annual Data
	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Days Payable	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Incanthera's Days Payable

For the Biotechnology subindustry, Incanthera's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Incanthera's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Incanthera's Days Payable distribution charts can be found below:

* The bar in red indicates where Incanthera's Days Payable falls into.

Incanthera Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Incanthera's Days Payable for the fiscal year that ended in Mar. 2023 is calculated as

	Days Payable (A: Mar. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Mar. 2022 )	+	Accounts Payable (A: Mar. 2023 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2023 )	*	Days in Period
=	( (0.196	+	0.145)	/	2 )	/	0	*	365
=	0.1705					/	0	*	365
=	N/A

Incanthera's Days Payable for the quarter that ended in Sep. 2023 is calculated as:

	Days Payable (Q: Sep. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Mar. 2023 )	+	Accounts Payable (Q: Sep. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2023 )	*	Days in Period
=	( (0.145	+	0.633)	/	2 )	/	0	*	365 / 2
=	0.389					/	0	*	365 / 2
=	N/A

Incanthera Days Payable Related Terms

Thank you for viewing the detailed overview of Incanthera's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Incanthera (AQSE:INC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

76 King Street, Manchester, GBR, M2 4NH

Website

http://www.incanthera.com

Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines